BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jenks JA, Nelson CS, Roark HK, Goodwin ML, Pass RF, Bernstein DI, Walter EB, Edwards KM, Wang D, Fu TM, An Z, Chan C, Permar SR. Antibody binding to native cytomegalovirus glycoprotein B predicts efficacy of the gB/MF59 vaccine in humans. Sci Transl Med 2020;12:eabb3611. [PMID: 33148624 DOI: 10.1126/scitranslmed.abb3611] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen JL, Fries CN, Berendam SJ, Rodgers NS, Roe EF, Wu Y, Li SH, Jain R, Watts B, Eudailey J, Barfield R, Chan C, Moody MA, Saunders KO, Pollara J, Permar SR, Collier JH, Fouda GG. Self-assembling peptide nanofiber HIV vaccine elicits robust vaccine-induced antibody functions and modulates Fc glycosylation. Sci Adv 2022;8:eabq0273. [PMID: 36149967 DOI: 10.1126/sciadv.abq0273] [Reference Citation Analysis]
2 Spencer Clinton JL, Hoornweg TE, Tan J, Peng R, Schaftenaar W, Rutten VPMG, de Haan CAM, Ling PD. EEHV1A glycoprotein B subunit vaccine elicits humoral and cell-mediated immune responses in mice. Vaccine 2022:S0264-410X(22)00891-X. [PMID: 35879117 DOI: 10.1016/j.vaccine.2022.07.016] [Reference Citation Analysis]
3 Etti M, Calvert A, Galiza E, Lim S, Khalil A, Le Doare K, Heath PT. Maternal vaccination: a review of current evidence and recommendations. Am J Obstet Gynecol 2022;226:459-74. [PMID: 34774821 DOI: 10.1016/j.ajog.2021.10.041] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
4 Pardieck IN, van Duikeren S, Veerkamp DMB, Brasem DJ, Redeker A, van Bergen J, Han W, Ossendorp F, Zondag G, Arens R. Dominant Antiviral CD8+ T Cell Responses Empower Prophylactic Antibody-Eliciting Vaccines Against Cytomegalovirus. Front Immunol 2022;13:680559. [PMID: 35154089 DOI: 10.3389/fimmu.2022.680559] [Reference Citation Analysis]
5 Eisfeld HS, Simonis A, Winter S, Chhen J, Ströh LJ, Krey T, Koch M, Theobald SJ, Rybniker J. Viral Glycoproteins Induce NLRP3 Inflammasome Activation and Pyroptosis in Macrophages. Viruses 2021;13:2076. [PMID: 34696506 DOI: 10.3390/v13102076] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
6 Webster H, Valencia S, Kumar A, Chan C, Dennis M, Roark H, Woods A, John S, Carfi A, Permar SR. Pre-existing immunity to cytomegalovirus in macaques influences human CMV vaccine responses in preclinical models. Vaccine 2021;39:5358-67. [PMID: 34393017 DOI: 10.1016/j.vaccine.2021.08.011] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Long X, Qiu Y, Zhang Z, Wu M. Insight for Immunotherapy of HCMV Infection. Int J Biol Sci 2021;17:2899-911. [PMID: 34345215 DOI: 10.7150/ijbs.58127] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Li L, Freed DC, Liu Y, Li F, Barrett DF, Xiong W, Ye X, Adler SP, Rupp RE, Wang D, Zhang N, Fu TM, An Z. A conditionally replication-defective cytomegalovirus vaccine elicits potent and diverse functional monoclonal antibodies in a phase I clinical trial. NPJ Vaccines 2021;6:79. [PMID: 34078915 DOI: 10.1038/s41541-021-00342-3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]